Dare Bioscience, Inc.(DARE)

$0.80—

Chart

Dare Bioscience, Inc.(DARE)

NASDAQ

$0.80—

Chart Studio

DARE(DARE)

DARE

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-0.14

Nov 12, 2026 · Reports after close

Revenue Estimate

$2M

FY2028E EPS$0.12

FY2029E EPS$1.51

Analyst Sentiment

Wall St. Consensus

Buy

6 analysts·Limited coverage

Score

6 Buy (100%)0 Hold (0%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

6100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$12.00

+1393.5%

Consensus

$12.00

+1393.5%

Bull

$12.00

+1393.5%

12-Month Target Range6 analysts

$12.00$12.00$12.00

Current $0.80Consensus

Current Price

$0.80

Upside to Consensus

$11.20

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+226.14%

EPS—

FY2028

Rev+318.16%

EPS—

FY2029

Rev+184.73%

EPS+1158.33%

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$3M	$9M	$37M	$106M	$240M
Low	$248,388	$6M	$29M	$73M	$167M
High	$5M	$12M	$45M	$143M	$326M
EBITDA Avg	$-2M	$-5M	$-22M	$-63M	$-144M
Low	$-3M	$-7M	$-27M	$-86M	$-196M
High	$-149,032	$-4M	$-17M	$-44M	$-100M
EBIT Avg	$-2M	$-5M	$-22M	$-63M	$-144M
Low	$-3M	$-7M	$-27M	$-86M	$-196M
High	$-149,032	$-4M	$-17M	$-44M	$-100M
Net Income Avg	$-88M	$-48M	$13M	$169M	$544M
Low	$-117M	$-68M	$7M	$102M	$328M
High	$-58M	$-28M	$20M	$248M	$798M
EPS Avg	$-0.78	$-0.41	$0.12	$1.51	$4.87
Low	$-1.04	$-0.61	$0.06	$0.91	$2.94
High	$-0.52	$-0.25	$0.18	$2.21	$7.13
Analysts (Rev / EPS)	2 / 2	1 / 1	2 / 2	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$2M	$359,333	$2M	$2M	$2M	$3M	$10M	$11M
Low	$2M	$359,333	$2M	$2M	$2M	$3M	$10M	$11M
High	$2M	$359,333	$2M	$2M	$2M	$3M	$10M	$11M
EBITDA Avg	$-1M	$-215,599	$-999,900	$-1M	$-1M	$-2M	$-6M	$-7M
Low	$-1M	$-215,599	$-999,900	$-1M	$-1M	$-2M	$-6M	$-7M
High	$-1M	$-215,599	$-999,900	$-1M	$-1M	$-2M	$-6M	$-7M
EBIT Avg	$-1M	$-215,599	$-999,900	$-1M	$-1M	$-2M	$-6M	$-7M
Low	$-1M	$-215,599	$-999,900	$-1M	$-1M	$-2M	$-6M	$-7M
High	$-1M	$-215,599	$-999,900	$-1M	$-1M	$-2M	$-6M	$-7M
Net Income Avg	$-2M	$-3M	$-2M	$-2M	$-1M	$-1M	—	—
Low	$-6M	$-4M	$-2M	$-2M	$-1M	$-1M	—	—
High	$2M	$-3M	$-2M	$-2M	$-1M	$-1M	—	—
EPS Avg	$-0.14	$-0.23	$-0.10	$-0.13	$-0.10	$-0.09	—	—
Low	$-0.42	$-0.28	$-0.10	$-0.13	$-0.10	$-0.09	—	—
High	$0.16	$-0.19	$-0.10	$-0.13	$-0.10	$-0.09	—	—
Analysts (Rev / EPS)	2 / 2	2 / 2	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Oct 24, 2024H.C. Wainwright

H.C. Wainwright Reiterates Buy Rating on Dare Bioscience (DARE)

Target:$12.00

+242.9%from $3.50

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance